海外の治験の状況「1」での検索結果
2290件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Inherited Retinal Degenerative Disease Registry
- Leber Congenital Amaurosis;Refsum Syndrome;Retinitis Pigmentosa;Retinitis Punctata Albescens;Retinoschisis;Rod-Cone Dystrophy;Rod Dystrophy;Rod Monochromacy;Stargardt Disease;Usher Syndrome;Eye Diseases Hereditary;Retinal Disease;Achromatopsia;Bardet-Biedl Syndrome;Bassen-Kornzweig Syndrome;Batten Disease;Best Disease;Choroidal Dystrophy;Choroideremia;Cone Dystrophy;Cone-Rod Dystrophy;Congenital Stationary Night Blindness;Enhanced S-Cone Syndrome;Fundus Albipunctatus;Goldmann-Favre Syndrome;Gyrate Atrophy;Juvenile Macular Degeneration;Kearns-Sayre Syndrome
- United States
- 2015-04-03
Recruiting
- Genetic Characterization of Movement Disorders and Dementias
- Ataxia;Dystonia;Parkinson's Disease;Amyotrophic Lateral Sclerosis;Corticobasal Degeneration;Multiple System Atrophy;Alzheimer's Disease;Lewy Body Dementia;Parkinson Disease-Dementia;Dentatorubral-pallidoluysian Atrophy;Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;Fragile X-associated Tremor/Ataxia Syndrome;Krabbe's Disease;Niemann-Pick Disease, Type C;Neuronal Ceroid Lipofuscinosis
- United States
- 2013-12-12
Recruiting
- North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
- Epilepsy; Seizure;Neuromuscular Diseases;Brain Malformation;Intellectual Disability;Autism Spectrum Disorder;Hypotonia;Inborn Errors of Metabolism;Movement Disorders;Genetic Disease;Development Delay;Chromosome Abnormality;Hearing Loss;Dysmorphic Features;Skeletal Dysplasia;Congenital Abnormality;Microcephaly;Macrocephaly;Epilepsy; Seizure;Neuromuscular Diseases;Brain Malformation;Intellectual Disability;Autism Spectrum Disorder;Hypotonia;Inborn Errors of Metabolism;Movement Disorders;Genetic Disease;Development Delay;Chromosome Abnormality;Hearing Loss;Dysmorphic Features;Skeletal Dysplasia;Congenital Abnormality;Microcephaly;Macrocephaly
- United States
- 2018-05-24
Recruiting
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;Blasts 5 Percent or More of Bone Marrow Nucleated Cells;Myelodysplastic/Myeloproliferative Neoplasm;Philadelphia Chromosome Positive;Recurrent Acute Lymphoblastic Leukemia;Recurrent Adult Acute Myeloid Leukemia;Refractory Acute Lymphoblastic Leukemia;Refractory Acute Myeloid Leukemia;Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Secondary Acute Myeloid Leukemia;T Acute Lymphoblastic Leukemia
- United States
- 2018-04-26
Recruiting
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
- Acute Myeloid Leukemia;Brain Glioblastoma;Estrogen Receptor Negative;Extensive Stage Small Cell Lung Carcinoma;Head and Neck Carcinoma;HER2/Neu Negative;Hormone-Resistant Prostate Cancer;Limited Stage Small Cell Lung Carcinoma;Myelodysplastic Syndrome;Progesterone Receptor Negative;Progressive Disease;Recurrent Carcinoma;Stage II Pancreatic Cancer;Stage II Rectal Cancer;Stage IIA Pancreatic Cancer;Stage IIA Rectal Cancer;Stage IIB Pancreatic Cancer;Stage IIB Rectal Cancer;Stage IIC Rectal Cancer;Stage III Colon Cancer;Stage III Esophageal Cancer;Stage III Gastric Cancer;Stage III Non-Small Cell Lung Cancer;Stage III Ovarian Cancer;Stage III Pancreatic Cancer;Stage III Rectal Cancer;Stage III Skin Melanoma;Stage IIIA Colon Cancer;Stage IIIA Esophageal Cancer;Stage IIIA Gastric Cancer;Stage IIIA Non-Small Cell Lung Cancer;Stage IIIA Ovarian Cancer;Stage IIIA Rectal Cancer;Stage IIIA Skin Melanoma;Stage IIIB Colon Cancer;Stage IIIB Esophageal Cancer;Stage IIIB Gastric Cancer;Stage IIIB Non-Small Cell Lung Cancer;Stage IIIB Ovarian Cancer;Stage IIIB Rectal Cancer;Stage IIIB Skin Melanoma;Stage IIIC Colon Cancer;Stage IIIC Esophageal Cancer;Stage IIIC Gastric Cancer;Stage IIIC Ovarian Cancer;Stage IIIC Rectal Cancer;Stage IIIC Skin Melanoma;Stage IV Bladder Cancer;Stage IV Bone Sarcoma;Stage IV Breast Cancer;Stage IV Colon Cancer;Stage IV Esophageal Cancer;Stage IV Gastric Cancer;Stage IV Non-Small Cell Lung Cancer;Stage IV Ovarian Cancer;Stage IV Pancreatic Cancer;Stage IV Rectal Cancer;Stage IV Renal Cell Cancer;Stage IV Skin Melanoma;Stage IV Soft Tissue Sarcoma;Stage IVA Bone Sarcoma;Stage IVA Colon Cancer;Stage IVA Rectal Cancer;Stage IVB Bone Sarcoma;Stage IVB Colon Cancer;Stage IVB Rectal Cancer;Triple-Negative Breast Carcinoma
- United States
- 2016-11-14
Recruiting
- Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia
- Post-transplant Lymphoproliferative Disorder;B-Cell Prolymphocytic Leukemia;Recurrent Adult Burkitt Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic Leukemia;Refractory Hairy Cell Leukemia;B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma;Recurrent Lymphoplasmacytic Lymphoma
- United States
- 2014-05-30
Recruiting
- Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
- NonHodgkin Lymphoma;Lymphoproliferative Disorders;EBV Related Lymphoma;EBV-Related PTLD;Hodgkin Lymphoma;EBV Related Non-Hodgkin's Lymphoma;EBV Related Hodgkin's Lymphoma
- United States
- 2016-11-22
Recruiting
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
- Post-Transplant Lymphoproliferative Disorder;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent B-Cell Non-Hodgkin Lymphoma;Recurrent Burkitt Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Burkitt Lymphoma;Refractory Diffuse Large B-Cell Lymphoma
- United States
- 2011-07-26
Recruiting
- TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
- B-Cell Non-Hodgkin Lymphoma;Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Lymphoplasmacytic Lymphoma;Mantle Cell Lymphoma;Marginal Zone Lymphoma;Small Lymphocytic Lymphoma
- United States
- 2018-01-19
Recruiting
- A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Cervical Cancer;Gastric Cancer;Stomach Cancer;Gastroesophageal Junction Cancer;Esophageal Cancer;Hepatocellular Carcinoma;Melanoma;Uveal Melanoma;Merkel Cell Carcinoma;Mesothelioma;MSI;Non-small Cell Lung Cancer;NSCLC;Ovarian Cancer;Squamous Cell Carcinoma of the Head and Neck;Small Cell Lung Cancer;Renal Cell Carcinoma;RCC;Triple-negative Breast Cancer;Urothelial Carcinoma;Mismatch Repair Deficiency
- United States
- 2018-08-28
Recruiting
- Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Grade 3a Follicular Lymphoma;Recurrent Burkitt Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Marginal Zone Lymphoma;Refractory Burkitt Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Transformed Recurrent Non-Hodgkin Lymphoma;B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma
- United States
- 2016-12-12
Recruiting
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Advanced Malignant Solid Neoplasm;Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma;Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma;BRAF NP_004324.2:p.V600X;Ependymoma;Ewing Sarcoma;Hepatoblastoma;Histiocytosis;Langerhans Cell Histiocytosis;Malignant Germ Cell Tumor;Malignant Glioma;Osteosarcoma;Peripheral Primitive Neuroectodermal Tumor;Recurrent Childhood Central Nervous System Neoplasm;Recurrent Childhood Non-Hodgkin Lymphoma;Recurrent Malignant Solid Neoplasm;Recurrent Neuroblastoma;Refractory Central Nervous System Neoplasm;Refractory Malignant Solid Neoplasm;Refractory Neuroblastoma;Refractory Non-Hodgkin Lymphoma;Rhabdoid Tumor;Rhabdomyosarcoma;Soft Tissue Sarcoma;Wilms Tumor
- Puerto Rico, United States
- 2017-07-17
Recruiting
- Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma
- Hematopoietic Cell Transplantation Recipient;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Non-Hodgkin Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Refractory Marginal Zone Lymphoma;Refractory Non-Hodgkin Lymphoma;Refractory Transformed Indolent Non-Hodgkin Lymphoma
- United States
- 2018-06-28
Recruiting
- Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
- Advanced Malignant Solid Neoplasm;RB1 Positive;Recurrent Childhood Ependymoma;Recurrent Ewing Sarcoma;Recurrent Glioma;Recurrent Hepatoblastoma;Recurrent Kidney Wilms Tumor;Recurrent Langerhans Cell Histiocytosis;Recurrent Malignant Germ Cell Tumor;Recurrent Malignant Glioma;Recurrent Medulloblastoma;Recurrent Neuroblastoma;Recurrent Non-Hodgkin Lymphoma;Recurrent Osteosarcoma;Recurrent Peripheral Primitive Neuroectodermal Tumor;Recurrent Rhabdoid Tumor;Recurrent Rhabdomyosarcoma;Recurrent Soft Tissue Sarcoma;Refractory Ependymoma;Refractory Ewing Sarcoma;Refractory Glioma;Refractory Hepatoblastoma;Refractory Langerhans Cell Histiocytosis;Refractory Malignant Germ Cell Tumor;Refractory Malignant Glioma;Refractory Medulloblastoma;Refractory Neuroblastoma;Refractory Non-Hodgkin Lymphoma;Refractory Osteosarcoma;Refractory Peripheral Primitive Neuroectodermal Tumor;Refractory Rhabdoid Tumor;Refractory Rhabdomyosarcoma;Refractory Soft Tissue Sarcoma
- Puerto Rico, United States
- 2018-05-15
Recruiting
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Cancer, Metastatic;Cancer;Cancer of Pancreas;Cancer of Liver;Cancer of Stomach;Cancer Liver;Cancer of Rectum;Cancer of Kidney;Cancer of Esophagus;Cancer of Cervix;Cancer of Colon;Cancer of Larynx;Cancer, Lung;Cancer, Breast;Cancer, Advanced;Cancer Prostate;Cancer of Neck;Cancer of Skin;Neuroendocrine Tumors;Carcinoma;Mismatch Repair Deficiency;BRCA Gene Rearrangement;Non Hodgkin Lymphoma;Leukemia;Non Small Cell Lung Cancer;Cholangiocarcinoma;Glioblastoma;Central Nervous System Tumor;Melanoma;Urothelial Carcinoma;Bladder Cancer;Ovarian Cancer;Endometrial Cancer;Testicular Cancer;Breast Cancer
- United States
- 2018-02-13
Recruiting
- Pembrolizumab and Vorinostat in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, or Hodgkin Lymphoma
- Grade 3a Follicular Lymphoma;Grade 3b Follicular Lymphoma;Recurrent Classical Hodgkin Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Refractory Classical Hodgkin Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma
- United States
- 2017-05-10
Recruiting
- Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
- Grade 3a Follicular Lymphoma;Recurrent Burkitt Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Lymphoplasmacytic Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Waldenstrom Macroglobulinemia;Refractory Burkitt Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Refractory Lymphoplasmacytic Lymphoma;Refractory Mantle Cell Lymphoma
- United States
- 2017-01-03
Recruiting
- Dystonia Genotype-Phenotype Correlation
- Dystonia;Dystonia; Idiopathic;Dystonia, Primary;Dystonia, Secondary;Dystonia, Familial;Dystonia Disorder;Dystonias, Sporadic;Dystonia; Orofacial;Dystonia Lenticularis;Dystonia, Paroxysmal;Dystonia 6;Dystonia 5;Dystonia 8;Dystonia 9;Dystonia 19;Dystonia 10;Dystonia 11;Dystonia 20;Dystonia 12;Dystonia, Focal;Dystonia of Head;Dystonia, Diurnal;Dystonia;Dystonia; Idiopathic;Dystonia, Primary;Dystonia, Secondary;Dystonia, Familial;Dystonia Disorder;Dystonias, Sporadic;Dystonia; Orofacial;Dystonia Lenticularis;Dystonia, Paroxysmal;Dystonia 6;Dystonia 5;Dystonia 8;Dystonia 9;Dystonia 19;Dystonia 10;Dystonia 11;Dystonia 20;Dystonia 12;Dystonia, Focal;Dystonia of Head;Dystonia, Diurnal;Dystonia;Dystonia; Idiopathic;Dystonia, Primary;Dystonia, Secondary;Dystonia, Familial;Dystonia Disorder;Dystonias, Sporadic;Dystonia; Orofacial;Dystonia Lenticularis;Dystonia, Paroxysmal;Dystonia 6;Dystonia 5;Dystonia 8;Dystonia 9;Dystonia 19;Dystonia 10;Dystonia 11;Dystonia 20;Dystonia 12;Dystonia, Focal;Dystonia of Head;Dystonia, Diurnal
- United States
- 2018-02-02
Recruiting
- Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
- Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;Stage IB Mycosis Fungoides AJCC v7;Stage II Mycosis Fungoides AJCC v7;Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma;Stage III Mycosis Fungoides AJCC v7;Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma;Stage IV Mycosis Fungoides AJCC v7;Follicular T-Cell Lymphoma;Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Recurrent Angioimmunoblastic T-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma;Recurrent Mycosis Fungoides;Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;Refractory Angioimmunoblastic T-Cell Lymphoma;Refractory Follicular Lymphoma
- Canada, United States
- 2015-08-10
Recruiting
- Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas
- Recurrent Chronic Lymphocytic Leukemia;Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Lymphoplasmacytic Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Nodal Marginal Zone Lymphoma;Recurrent Small Lymphocytic Lymphoma;Recurrent Splenic Marginal Zone Lymphoma;Refractory Chronic Lymphocytic Leukemia;Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;Refractory Follicular Lymphoma;Refractory Lymphoplasmacytic Lymphoma;Refractory Nodal Marginal Zone Lymphoma;Refractory Small Lymphocytic Lymphoma;Refractory Splenic Marginal Zone Lymphoma;Richter Syndrome;Waldenstrom Macroglobulinemia
- United States
- 2015-01-05
